Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
Clinical trial NCT01473524 · COMPLETED
Trial details
- NCT number
- NCT01473524
- Sponsor
- Intercept Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.